FAST Congress  
  • Slide 3
  • Slide 4
  • Slide 1


Geraldine HamiltonGeraldine A. Hamilton, Ph.D.
Senior Staff Scientist, Wyss Institute for Biologically Inspired Engineering, Harvard University

Jing LiJing Li, Ph.D.
Director, Genomics and Phenotypic Screening, Merck

Alan WellsAlan H. Wells, M.D., D.M.Sc.
Vice Chair and Thomas J. Gill III Professor, Pathology, University of Pittsburgh

John WikswoJohn P. Wikswo, Ph.D.
Founding Director, Vanderbilt Institute for Integrative Biosystems Research and Education and Gordon A. Cain University Professor, Vanderbilt University

George ChurchGeorge Church, Ph.D.
Professor, Health Sciences and Technology, Harvard and MIT; Founding Core Faculty Member, Wyss Institute for Biologically Inspired Engineering, Harvard University

Anna CollénAnna Collén
Director, Reagents and Assay Development, AstraZeneca

Kristin FabreKristin Fabre, Ph.D.
Scientific Program Manager, NCATS, National Institutes of Health

Meir GlickMeir Glick, Ph.D.
Head, In Silico Lead Discovery, Center for Proteomic Chemistry, Novartis


Join us in Boston this coming Fall to attend Cambridge Healthtech Institute's (CHI) 2nd Annual FAST: Functional Analysis & Screening Technologies Congress on November 17-19, 2014 and meet with a community of 250+ biologists, screening managers, assay developers, engineers and pharmacologists dedicated to improving in vitro cell models and phenotypic screening to advance drug discovery and development at 6 conferences: Phenotypic Drug Discovery (Part I & II), Engineering Functional 3D Models, Screening and Functional Analysis of 3D Models, Organotypic Culture Models for Toxicology and Physiologically-Relevant Cellular Tumor Models for Drug Discovery. Delegates have the opportunity to share insights in interactive panel discussions and connect during networking breaks. View innovative technologies and scientific research revolutionizing early-stage drug discovery in the exhibit/poster hall. Here’s what past attendees had to say about the 2013 Congress: